Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Johanna Kuhlin
Observed names:
J. Kuhlin,
Johanna Kuhlin (18679120),
Kuhlin, J,
Kuhlin, Johanna
Institutions:
Karolinska University Hospital,
University of Cape Town,
Karolinska Institutet,
Wellcome Centre for Infectious Diseases Research in Africa,
Institute of Infectious Disease and Molecular Medicine
Observed institutions:
Karolinska University Hospital,
University of Cape Town,
Karolinska Institutet,
London School of Hygiene & Tropical Medicine,
Wellcome Centre for Infectious Diseases Research in Africa,
Institute of Infectious Disease and Molecular Medicine
show all 6
ORCID:
0000-0002-3398-2421
Observed ORCID:
0000-0002-3398-2421
OpenAlex ID:
A5017350057
Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs
2018
·
Johanna Kuhlin
, Marieke G.G. Sturkenboom
, et al.
·
Clinical mass spectrometry
·
38
Development and validation of a simple LC-MS/MS method for simultaneous determination of moxifloxacin, levofloxacin, prothionamide, pyrazinamide and ethambutol in human plasma
2020
·
Xubin Zheng
, Erwin M. Jongedijk
, et al.
·
Journal of Chromatography B
·
34
PDF
Treatment outcomes of bedaquiline-resistant tuberculosis: a retrospective and matched cohort study
2025
·
Lindokuhle Mdlenyani
, Zahraa Mohamed
, et al.
·
The Lancet Infectious Diseases
·
32
PDF
Increased risk of adverse drug reactions by higher linezolid dose per weight in multidrug-resistant tuberculosis
2024
·
Johanna Kuhlin
, Lina Davies Forsman
, et al.
·
International Journal of Antimicrobial Agents
·
18
Suboptimal moxifloxacin and levofloxacin drug exposure during treatment of patients with multidrug-resistant tuberculosis: results from a prospective study in China
2020
·
Lina Davies Forsman
, Katarina Niward
, et al.
·
European Respiratory Journal
·
18
PDF
Genotypic Resistance of Pyrazinamide but Not Minimum Inhibitory Concentration Is Associated With Longer Time to Sputum Culture Conversion in Patients With Multidrug-resistant Tuberculosis
2020
·
Johanna Kuhlin
, Lina Davies Forsman
, et al.
·
Clinical Infectious Diseases
·
15
Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan
2018
·
J. Kuhlin
, C. Smith
, et al.
·
The International Journal of Tuberculosis and Lung Disease
·
12
Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort study
2020
·
Simone HJ van den Elsen
, Marieke GG Sturkenboom
, et al.
·
BMJ Open
·
11
PDF
Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort study
2018
·
Lina Davies Forsman
, Katarina Niward
, et al.
·
BMJ Open
·
9
PDF
Treatment Outcomes With an Oral Short Course Regimen for Rifampicin-resistant Tuberculosis in a High HIV Prevalence, Programmatic Setting in South Africa
2025
·
Jacob A M Stadler
, Johanna Kuhlin
, et al.
·
Clinical Infectious Diseases
·
8
PDF
Is there a need to optimise pyrazinamide doses in patients with tuberculosis? A systematic review
2023
·
Ricky Hao Chen
, Toni Michael
, et al.
·
International Journal of Antimicrobial Agents
·
8
Research Protocol - Effectiveness of a simplified short regimen for Multidrug Resistant Tuberculosis treatment in Karakalpakstan, Uzbekistan
2014
·
Philipp du Cros
, Khamraev Atadjan
, et al.
·
Medecins Sans Frontieres Field Research (Medecins Sans Frontieres)
·
5
Understanding tuberculosis among people with tuberculosis through an educational film: a qualitative study
2025
·
Elin Economou Lundeberg
, Olivia Biermann
, et al.
·
BMJ Open
·
1
Corrigendum to “Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs” [Clin. Mass Spectrom. 14(Part A) (2019) 34–45]
2022
·
Johanna Kuhlin
, Marieke G.G. Sturkenboom
, et al.
·
Journal of Mass Spectrometry and Advances in the Clinical Lab
·
1
PDF
Treatment Adherence With an Oral 9-Month Regimen for Rifampicin-Resistant Tuberculosis in South Africa
2026
·
Johanna Kuhlin
, Jacob A M Stadler
, et al.
·
Clinical Infectious Diseases
Correction to: Treatment Outcomes With an Oral Short Course Regimen for Rifampicin-resistant Tuberculosis in a High HIV Prevalence, Programmatic Setting in South Africa
2025
·
Stadler, JAM
, Kuhlin, J
, et al.
·
Clinical Infectious Diseases
[Is it time to use sputum induction as a complementary specimen collection procedure in adult patients with suspected pulmonary tuberculosis?]
2020
·
Johanna Kuhlin
, Ann Tammelin
, et al.
·
PubMed
The impact of pyrazinamide resistance upon the treatment outcome of patients with multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan
2017
·
Johanna Kuhlin
, Chris Smith
, et al.
Show more works
View as search
Works count:
20
Citation count:
211
H-index:
9
I10-index:
8
Year
Topic
Type